Paladin Labs Inc. (CC:PLB) Reports Record Third Quarter 2009 Financial Results
11/11/2009 11:06:54 AM
More...
|
Paladin Labs Inc. (CC:PLB) Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research From Bill & Melinda Gates Foundation
10/23/2009 9:48:09 AM
More...
|
Paladin Labs Inc. (CC:PLB) and Pfizer Inc. (PFE) (JOBS) Amend Canadian Estring(R) Agreement
10/15/2009 6:27:22 AM
More...
|
Paladin Labs Inc. (CC:PLB) to Present at BioContact Conference in Quebec City
10/1/2009 11:35:27 AM
More...
|
Paladin Labs Inc. (CC:PLB) Announces Sale of Antibody Platform to Quest PharmaTech Inc.
9/30/2009 10:58:20 AM
More...
|
Health Canada Approves Paladin Labs Inc. (CC:PLB)'s GlucaGen(R) for Treatment of Severe Hypoglycemia in Diabetes Patients
9/24/2009 10:55:12 AM
More...
|
Paladin Labs Inc. (CC:PLB) to Present at the UBS Global Life Sciences Conference in New York City
9/18/2009 10:37:20 AM
More...
|
Paladin Labs Inc. (CC:PLB) Announces Sale of T-ACT Platform to IMBiotechnologies
8/14/2009 10:31:53 AM
More...
|
Paladin Labs Inc. (CC:PLB) Reports 2009 Second Quarter Financial Results
8/11/2009 9:51:11 AM
More...
|
Paladin Labs Inc. (CC:PLB) Reports 2009 Second Quarter Financial Results
8/11/2009 9:43:46 AM
More...
|
|